Identification of Immunopotentiating Lactic Acid Bacteria that Induce Antibody Production by in vitro Stimulated Human Peripheral Blood Mononuclear Cells

Makiko Yamashita, Akira Hitaka, Himiko Fujino, Takashi Matsumoto, Takanori Hasegawa, Fumiki Morimatsu, Tsukasa Fujiki, Yoshinori Katakura

Research output: Contribution to journalArticle

Abstract

L-leucyl-L-leucine methyl ester (LLME) is known to remove lysosome-rich cells from human peripheral blood mononuclear cells (PBMCs). To evaluate the immunopotentiating ability of lactic acid bacteria (LAB), we adopted the in vitro stimulation protocol of LLME-treated PBMCs as a model assay system and monitored the level of antibody produced by stimulated PBMCs. The results indicated that several LAB strains have immunopotentiating ability against PBMCs, as evidenced by the enhanced antibody production and increased number of antigen-specific B cells. Next, we identified T cells as the direct target cells of the immunopotentiating LAB strain L32, suggesting that L32 induced antibody production by PBMCs through T-cell activation. Finally, we tested the immunopotentiating ability of ligands for Toll-like receptor 2 (TLR2), which is known to mediate the LAB signal, and observed that both L32 and one of the TLR2 ligands, LTA-BS, induced antigen-specific antibody production by in vitro stimulated PBMC. This suggests that L32 and LTA-BS can be used as an adjuvant for stimulating immune reaction in PBMCs.

Original languageEnglish
Pages (from-to)7-13
Number of pages7
JournalBioscience of Microbiota, Food and Health
Volume31
Issue number1
DOIs
Publication statusPublished - 2012

Fingerprint

antibody formation
mononuclear leukocytes
lactic acid bacteria
Antibody Formation
Lactic Acid
Blood Cells
Bacteria
leucylleucine
Toll-Like Receptor 2
leucine
T-lymphocytes
esters
Ligands
antigens
T-Lymphocytes
Antigens
lysosomes
Lysosomes
In Vitro Techniques
adjuvants

Cite this

Identification of Immunopotentiating Lactic Acid Bacteria that Induce Antibody Production by in vitro Stimulated Human Peripheral Blood Mononuclear Cells. / Yamashita, Makiko; Hitaka, Akira; Fujino, Himiko; Matsumoto, Takashi; Hasegawa, Takanori; Morimatsu, Fumiki; Fujiki, Tsukasa; Katakura, Yoshinori.

In: Bioscience of Microbiota, Food and Health, Vol. 31, No. 1, 2012, p. 7-13.

Research output: Contribution to journalArticle

Yamashita, Makiko ; Hitaka, Akira ; Fujino, Himiko ; Matsumoto, Takashi ; Hasegawa, Takanori ; Morimatsu, Fumiki ; Fujiki, Tsukasa ; Katakura, Yoshinori. / Identification of Immunopotentiating Lactic Acid Bacteria that Induce Antibody Production by in vitro Stimulated Human Peripheral Blood Mononuclear Cells. In: Bioscience of Microbiota, Food and Health. 2012 ; Vol. 31, No. 1. pp. 7-13.
@article{e3a59b5fc9a5484ca8261fb1ba1c0b56,
title = "Identification of Immunopotentiating Lactic Acid Bacteria that Induce Antibody Production by in vitro Stimulated Human Peripheral Blood Mononuclear Cells",
abstract = "L-leucyl-L-leucine methyl ester (LLME) is known to remove lysosome-rich cells from human peripheral blood mononuclear cells (PBMCs). To evaluate the immunopotentiating ability of lactic acid bacteria (LAB), we adopted the in vitro stimulation protocol of LLME-treated PBMCs as a model assay system and monitored the level of antibody produced by stimulated PBMCs. The results indicated that several LAB strains have immunopotentiating ability against PBMCs, as evidenced by the enhanced antibody production and increased number of antigen-specific B cells. Next, we identified T cells as the direct target cells of the immunopotentiating LAB strain L32, suggesting that L32 induced antibody production by PBMCs through T-cell activation. Finally, we tested the immunopotentiating ability of ligands for Toll-like receptor 2 (TLR2), which is known to mediate the LAB signal, and observed that both L32 and one of the TLR2 ligands, LTA-BS, induced antigen-specific antibody production by in vitro stimulated PBMC. This suggests that L32 and LTA-BS can be used as an adjuvant for stimulating immune reaction in PBMCs.",
author = "Makiko Yamashita and Akira Hitaka and Himiko Fujino and Takashi Matsumoto and Takanori Hasegawa and Fumiki Morimatsu and Tsukasa Fujiki and Yoshinori Katakura",
year = "2012",
doi = "10.12938/bmfh.31.7",
language = "English",
volume = "31",
pages = "7--13",
journal = "Bioscience of Microbiota, Food and Health",
issn = "2186-3342",
publisher = "BMFH Press",
number = "1",

}

TY - JOUR

T1 - Identification of Immunopotentiating Lactic Acid Bacteria that Induce Antibody Production by in vitro Stimulated Human Peripheral Blood Mononuclear Cells

AU - Yamashita, Makiko

AU - Hitaka, Akira

AU - Fujino, Himiko

AU - Matsumoto, Takashi

AU - Hasegawa, Takanori

AU - Morimatsu, Fumiki

AU - Fujiki, Tsukasa

AU - Katakura, Yoshinori

PY - 2012

Y1 - 2012

N2 - L-leucyl-L-leucine methyl ester (LLME) is known to remove lysosome-rich cells from human peripheral blood mononuclear cells (PBMCs). To evaluate the immunopotentiating ability of lactic acid bacteria (LAB), we adopted the in vitro stimulation protocol of LLME-treated PBMCs as a model assay system and monitored the level of antibody produced by stimulated PBMCs. The results indicated that several LAB strains have immunopotentiating ability against PBMCs, as evidenced by the enhanced antibody production and increased number of antigen-specific B cells. Next, we identified T cells as the direct target cells of the immunopotentiating LAB strain L32, suggesting that L32 induced antibody production by PBMCs through T-cell activation. Finally, we tested the immunopotentiating ability of ligands for Toll-like receptor 2 (TLR2), which is known to mediate the LAB signal, and observed that both L32 and one of the TLR2 ligands, LTA-BS, induced antigen-specific antibody production by in vitro stimulated PBMC. This suggests that L32 and LTA-BS can be used as an adjuvant for stimulating immune reaction in PBMCs.

AB - L-leucyl-L-leucine methyl ester (LLME) is known to remove lysosome-rich cells from human peripheral blood mononuclear cells (PBMCs). To evaluate the immunopotentiating ability of lactic acid bacteria (LAB), we adopted the in vitro stimulation protocol of LLME-treated PBMCs as a model assay system and monitored the level of antibody produced by stimulated PBMCs. The results indicated that several LAB strains have immunopotentiating ability against PBMCs, as evidenced by the enhanced antibody production and increased number of antigen-specific B cells. Next, we identified T cells as the direct target cells of the immunopotentiating LAB strain L32, suggesting that L32 induced antibody production by PBMCs through T-cell activation. Finally, we tested the immunopotentiating ability of ligands for Toll-like receptor 2 (TLR2), which is known to mediate the LAB signal, and observed that both L32 and one of the TLR2 ligands, LTA-BS, induced antigen-specific antibody production by in vitro stimulated PBMC. This suggests that L32 and LTA-BS can be used as an adjuvant for stimulating immune reaction in PBMCs.

U2 - 10.12938/bmfh.31.7

DO - 10.12938/bmfh.31.7

M3 - Article

VL - 31

SP - 7

EP - 13

JO - Bioscience of Microbiota, Food and Health

JF - Bioscience of Microbiota, Food and Health

SN - 2186-3342

IS - 1

ER -